$3.6MSeed, 20 April 2026
Oversubscribed seed to commercialize virtual staining and validate biomarker panels.
- Amount
- $3.6M
- Stage
- Seed
- Announced
- 20 April 2026
- Lead
- Wittington Ventures
- Other investors
- Mayo Clinic, Continuum Health
- Use of funds
- Oversubscribed seed to commercialize virtual staining and validate biomarker panels.
- Checked
- Amount and date matched across 2 press sources
- Sources
- ViewsML raises $4.9M seed for virtual biomarker staining betakit.com
ViewsML raises $4.9M seed for virtual biomarker staining techstartups.com